Agenda

Moderator:
Steven Vold, MD

Participants:
John Berdahl, MD
Chris Calcaterra, Chief Commercial Officer – Glaukos
Richard Lewis, MD

Moderator:
Vance Thompson, MD

Participants:
Eric Donnenfeld, MD
Rajesh K. Rajpal, MD, Chief Medical Officer – Avedro
John Vukich, MD

Moderator:
Emmett T. Cunningham Jr., MD, PhD, MPH, Partner – Clarus Ventures

Participants:
Wiley Chambers, Deputy Director, Division of Transplant & Ophthalmology Products Center for Drug Evaluation & Research – FDA
Malvina B. Eydelman, MD, Director, Division of Ophthalmic & Ear, Nose & Throat Devices – FDA

Moderator:
Edward Holland, MD

Participants:
Michael Ackermann, PhD, VP, Neurostimulation – Allergan
Kim Brazzell, PhD, Chief Medical Officer – Kala Pharmaceuticals
John Sheppard, MD

Moderator:
Richard Lindstrom, MD

Participants:
Mark Baum, CEO – Imprimis Pharmaceuticals
Adnan Butt, Biotechnology Analyst – RBC Capital Markets
Eugene de Juan, MD, Founder & Vice Chairman – ForSight Labs
Amar Sawhney, PhD, President, CEO & Chairman – Ocular Therapeutix
Hartaj Singh, Analyst – BTIG

• 9:00 – 9:05 | PowerVision | Barry Cheskin, President, CEO & Co-Founder
• 9:05 – 9:10 | Refocus Group | Mike Judy, CEO
• 9:10 – 9:15 | ReVision Optics | John Kilcoyne, President & CEO
• 9:15 – 9:20 | Encore Vision | Bill Burns, President & CEO
• 9:20 – 9:25 | ClarVista Medical | Paul McLean, CEO
• 9:25 – 9:30 | Mynosys Cellular Devices | John Hendrick, President & CEO
• 9:30 – 9:35 | International Biomedical Devices | Mark Packer, MD, Chief Medical Officer
• 9:35 – 9:40 | Cassini | Mark Packer, MD, Chief Medical Officer
• 9:40 – 9:45 | TearScience | Joseph Boorady, President & CEO
• 9:45 – 9:50 | Aerie Pharmaceuticals | Tom Mitro, President & COO
• 9:50 – 9:55 | ForSight VISION5 | James Brandt, MD, Principal Investigator
• 9:55 – 10:00 | Ocular Therapeutix | Amar Sawhney, PhD, President, CEO & Chairman
• 10:00 – 10:05 | Avedro | Rajesh K. Rajpal, MD, Chief Medical Officer

Richard Lindstrom, MD

• TearLab | Seph Jensen, CEO
• Alcon | Seba Leoni, VP & Global Head, Surgical Suite
• Carl Zeiss Meditec AG | Karlheinz Rein, PhD, VP, Product Marketing Cataract & Retina Surgery
• Heidelberg Engineering | Kester Nahen, PhD, Managing Director

Moderator:
Richard Lindstrom, MD

Participants:
Tom Frinzi, President – AMO, SVP – Abbott Laboratories
Dave Harmon, President – Market Scope
Warren Hill, MD
Ludwin Monz, PhD, President & CEO – Carl Zeiss Meditec AG
Jay Pepose, MD, PhD
Vance Thompson, MD

Elizabeth Yeu, MD

• AcuFocus | Nick Tarantino, OD, Chief Global Clinical & Regulatory Affairs Officer
• Bausch + Lomb | Andrew Chang, General Manager & VP, US Surgical
• Abbott Medical Optics | Leonard Borrmann, Divisional VP, R&D
• Alcon | Michael Onuscheck, Global Franchise Head, Alcon Surgical

Moderator:
Elizabeth Yeu, MD

Participants:
David Chang, MD
Eric Donnenfeld, MD
Sherman Reeves, MD, MPH
Denise Visco, MD

Interviewed By:
Stephen Lane, MD

Co-Moderators:
Gilbert H. Kliman, MD, Managing Director – InterWest Partners
Stephen Slade, MD

• Equinox | John Berdahl, MD, Founder & CEO
• Presbyopia Therapies | Jim McCollum, Co-Founder
• Stroma Medical | Doug Daniels, CEO
• Eyenovia | Curt LaBelle, MD, Director
• Wicab | Robert Beckman, President & COO

Ike Ahmed, MD

• Taking a MIGS company public: Glaukos | Chris Calcaterra, Chief Commercial Officer
• Acquiring a MIGS company: Allergan | Dave LeCause, VP, US Eye Care
• FDA and MIGS evolving guidance: Transcend | Sean Ianchulev, MD, MPH, Chief Medical Officer
• Differentiating MIGS devices and the cataract surgeon: Ivantis | Dave Van Meter, President & CEO
• Glaucoma device development beyond MIGS: InnFocus | Russ Trenary, President & CEO

Moderator:
Ike Ahmed, MD

Participants:
Robert Cionni, MD
Richard Lewis, MD
Jai G. Parekh, MD, MBA

Participants:
Mike Ball, CEO – Alcon
Tom Frinzi, President – AMO, SVP – Abbott Laboratories
William J. Link, PhD, Managing Director – Versant Ventures
Ashley McEvoy, Company Group Chairman – Johnson & Johnson Vision Care
William Meury, EVP, President Branded Pharma – Allergan
Ludwin Monz, PhD, President & CEO – Carl Zeiss Meditec AG
Calvin Roberts, MD, SVP & Chief Medical Officer – Bausch + Lomb